Administer Oy provided earnings guidance for the year 2022. For the year, the company expects net sales will increase to at least EUR 51 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.4 EUR | 0.00% | -3.23% | -0.41% |
04-22 | BioXcel Therapeutics to Launch At-Home Trial of Potential Bipolar, Schizophrenia Agitation Treatment | MT |
04-11 | Gerresheimer shares down on outlook, but key contracts confirmed | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.41% | 37.48M | |
-7.18% | 318M | |
-.--% | 62.2M | |
-22.79% | 58.7M | |
-26.77% | 55.49M |
- Stock Market
- Equities
- ADMIN Stock
- News Administer Oyj
- Administer Oy Provides Earnings Guidance for the Year 2022